Further investigation to clarify the detailed molecular mechanisms underlying the effects of EP4 signaling on macrophage differentiation and polarization in other insulin-target organs will provide new insights into the pathogenesis, as well as novel therapeutic targets, of obesity-related insulin resistance and T2DM. This evidence concerns the gene INS and obesity disorder.